Showing results (221-230 of 246) with videos related to
Sort By:
Pageof 25
The Journal of Clinical Investigation|November 1, 2022
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancerShuang G Zhao, Jamie M Sperger, Jennifer L Schehr, et al.Nature Genetics|April 4, 2018
The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.Nature Biotechnology|October 22, 2013
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencingGarrett M Frampton, Alex Fichtenholtz, Geoff A Otto, et al.JU Open Plus|May 22, 2024
Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1E David Crawford, Alan H Bryce, Maha H Hussain, et al.Nature Genetics|June 2, 2019
Publisher Correction: The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.Cell|September 10, 2014
Organoid cultures derived from patients with advanced prostate cancerDong Gao, Ian Vela, Andrea Sboner, et al.Cancer Discovery|April 1, 2025
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical OutcomesMarina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.JAMA Oncology|July 17, 2015
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment ResponseHimisha Beltran, Kenneth Eng, Juan Miguel Mosquera, et al.Nature Communications|March 31, 2021
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancerSylvan C Baca, David Y Takeda, Ji-Heui Seo, et al.Cancer Discovery|February 6, 2025
High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomesMarina N Sharifi, Jamie M Sperger, Amy K Taylor, et al.Pageof 25